MIBS Oncology Hospital Opens in St. Petersburg

Photo Source: MIBS

Investment in the project totaled approximately 11 billion rubles, MIBS Board Chairman Arkady Stolpner told Marus Media.

The hospital has a total area of 29,600 square meters with 200 beds, expandable to 370. The facility includes three integrated operating rooms, emergency, hybrid with angiography, and universal. The diagnostic facility includes two MRI scanners (1.5 and 3 Tesla), two CT scanners, PET/CT, and SPECT/CT. Three linear accelerators are installed for radiation therapy, Halcyon and two TrueBeam for radiosurgery, as well as brachytherapy equipment.

The hospital has separate admission areas for adults and children, six single-bed intensive care units for adult patients, and a separate pediatric intensive care unit. Additionally, the 11-story building houses a day hospital and laboratory complex with pathomorphology and molecular genetics laboratories equipped with two NGS sequencers. Endoscopy and rehabilitation departments also operate, along with a physician training center.

Eight wards for theranostics are planned to open in 2027. Construction of a high-dose chemotherapy and CAR-T therapy unit is underway. The outpatient department and an additional PET/CT are located in the Proton Therapy Center building.

MIBS (Medical Institute named after Sergey Berezin) is a network of clinics founded in 2003 by physician Sergey Berezin and entrepreneur Arkady Stolpner. The company's first asset was a private MRI center in St. Petersburg. Today, MIBS includes 79 medical assets, a network of MRI and CT diagnostic centers in over 60 cities in Russia and neighboring countries, an oncology hospital, a Proton Therapy Center, and nuclear medicine centers (PET/CT, radionuclide therapy, radiopharmaceutical production) in St. Petersburg, Novosibirsk, Tomsk, Barnaul, and Tver. Revenue in 2024 was 11.7 billion rubles.

Source: Marus Media